Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril (2013)

  • Authors:
  • USP affiliated authors: LACCHINI, RICCARDO - FMRP ; SILVA JUNIOR, WILSON ARAÚJO DA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
  • USP Schools: FMRP; FMRP; FMRP
  • DOI: 10.1007/s00228-012-1326-2
  • Subjects: ÓXIDO NÍTRICO; POLIMORFISMO; HIPERTENSÃO; FÁRMACOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00228-012-1326-2 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2406225pcd 2406225 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, P. S.; FONTANA, V.; LUIZON, Marcelo Rizzatti; et al. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril. European Journal of Clinical Pharmacology, Heidelberg, v. 69, n. 2, p. 167-177, 2013. Disponível em: < http://dx.doi.org/10.1007/s00228-012-1326-2 > DOI: 10.1007/s00228-012-1326-2.
    • APA

      Silva, P. S., Fontana, V., Luizon, M. R., Lacchini, R., Silva Júnior, W. A. da, Biagi, C., & Tanus-Santos, J. E. (2013). eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril. European Journal of Clinical Pharmacology, 69( 2), 167-177. doi:10.1007/s00228-012-1326-2
    • NLM

      Silva PS, Fontana V, Luizon MR, Lacchini R, Silva Júnior WA da, Biagi C, Tanus-Santos JE. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 2): 167-177.Available from: http://dx.doi.org/10.1007/s00228-012-1326-2
    • Vancouver

      Silva PS, Fontana V, Luizon MR, Lacchini R, Silva Júnior WA da, Biagi C, Tanus-Santos JE. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 2): 167-177.Available from: http://dx.doi.org/10.1007/s00228-012-1326-2

    Referências citadas na obra
    Lawes CM, Vander Hoorn S, Rodgers A (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371(9623):1513–1518
    Linz W, Wohlfart P, Scholkens BA, Malinski T, Wiemer G (1999) Interactions among ACE, kinins and NO. Cardiovasc Res 43(3):549–561
    Mason RP, Cockcroft JR (2006) Targeting nitric oxide with drug therapy. J Clin Hypertens (Greenwich) 8(12 Suppl 4):40–52
    Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005) The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99(1):6–38
    Bachetti T, Comini L, Pasini E, Cargnoni A, Curello S, Ferrari R (2001) Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats. J Mol Cell Cardiol 33(3):395–403
    Comini L, Bachetti T, Cargnoni A, Bastianon D, Gitti GL, Ceconi C, Ferrari R (2007) Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent. Pharmacol Res 56(1):42–48
    De Gennaro CV, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516(3):253–259
    Miguel-Carrasco JL, Monserrat MT, Mate A, Vazquez CM (2010) Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. Eur J Pharmacol 632(1–3):65–72
    Hornig B, Kohler C, Drexler H (1997) Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 95(5):1115–1118
    Joshi MS, Mineo C, Shaul PW, Bauer JA (2007) Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 21(11):2655–2663
    Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, Harada M, Kajiyama N, Kishimoto I, Kuwahara K, Hino J, Ogawa E, Hamanaka I, Kamitani S, Takahashi N, Kawakami R, Kangawa K, Yasue H, Nakao K (2000) Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T–> C mutation associated with coronary spastic angina. Hum Mol Genet 9(18):2629–2637
    Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786–> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22):2864–2870
    Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Chen L, Zhang Y, Coselli JS, Wang XL (2008) Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell 19(9):3997–4005
    Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Zhang Y, Coselli J, Wang XL (2008) Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem 283(21):14685–14693
    Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE (2011) Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 11(6):393–399
    Metzger IF, Sertorio JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43(6):987–992
    Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, Tanus-Santos JE (2005) Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15(8):565–570
    Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ (2002) The T-786–> C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39(4):919–922
    Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Sikdar S, Gupta M, Javed S, Pasha MA (2008) Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic Biol Med 44(11):1912–1918
    Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2008) eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9(10):1467–1473
    Vasconcellos V, Lacchini R, Jacob-Ferreira AL, Sales ML, Ferreira-Sae MC, Schreiber R, Nadruz W, Tanus-Santos JE (2010) Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy. DNA Cell Biol 29(4):171–176
    Lee YC, Wu WJ, Liu CC, Wang CJ, Li WM, Huang CH, Yeh HC, Ke HL, Huang SP (2009) The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms. J Sex Med 6(11):3158–3165
    Napoli C, Ignarro LJ (2007) Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol 60(4):341–344
    Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186(2):428–432
    Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189(1):241–246
    Braun A, Kammerer S, Maier E, Bohme E, Roscher AA (1996) Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 33(1–3):32–35
    Braun A, Maier E, Kammerer S, Muller B, Roscher AA (1996) A novel sequence polymorphism in the promoter region of the human B2-bradykinin receptor gene. Hum Genet 97(5):688–689
    Dhamrait SS, Payne JR, Li P, Jones A, Toor IS, Cooper JA, Hawe E, Palmen JM, Wootton PT, Miller GJ, Humphries SE, Montgomery HE (2003) Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension. Eur Heart J 24(18):1672–1680
    Hallberg P, Lind L, Michaelsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Melhus H (2003) B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 21(3):621–624
    Niu W, Qi Y, Gao P, Zhu D (2010) A meta-analysis of the bradykinin B2 receptor gene –58C/T polymorphism with hypertension. Clin Chim Acta 411(5–6):324–328
    Lacchini R, Silva PS, Tanus-Santos JE (2010) A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 106(5):357–361
    Muniz JJ, Lacchini R, Rinaldi TO, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE (2011) Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. Pharmacogenomics J
    Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE (2006) eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 41(7):1044–1049
    Peskircioglu L, Atac FB, Erdem SR, Deveci S, Verdi H, Ozkardes H (2007) The association between intron 4 VNTR, E298A and IVF 23 + 10G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 19(2):149–153
    Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ (2008) Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension 51(2):454–459
    Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11(8):719–725
    Pretorius MM, Gainer JV, Van Guilder GP, Coelho EB, Luther JM, Fong P, Rosenbaum DD, Malave HA, Yu C, Ritchie MD, Vaughan DE, Brown NJ (2008) The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clin Pharmacol Ther 83(1):122–129
    Menashe I, Rosenberg PS, Chen BE (2008) PGA: power calculator for case-control genetic association analyses. BMC Genet 9:36
    Pander J, Wessels JA, Mathijssen RH, Gelderblom H, Guchelaar HJ (2011) Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle. Pharmacogenomics 11(7):1011–1017
    Ritchie MD, Motsinger AA (2005) Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics 6(8):823–834
    Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH (2011) A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Ann Hum Genet 75(1):20–28
    Abe K, Nakayama M, Yoshimura M, Nakamura S, Ito T, Yamamuro M, Sakamoto T, Miyamoto Y, Yoshimasa Y, Saito Y, Nakao K, Yasue H, Ogawa H (2005) Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T > C polymorphism. Pharmacogenet Genomics 15(5):329–336
    Mason RP, Jacob RF, Kubant R, Jacoby A, Louka F, Corbalan JJ, Malinski T (2012) Effects of angiotensin receptor blockers on endothelial nitric oxide release - The role of eNOS variants. Br J Clin Pharmacol
    Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE (2007) Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 193(2):438–444
    Nagassaki S, Herculano RD, Graeff CF, Tanus-Santos JE (2009) eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. Eur J Clin Pharmacol 65(4):385–392
    Tanus-Santos JE, Desai M, Deak LR, Pezzullo JC, Abernethy DR, Flockhart DA, Freedman JE (2002) Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12(5):407–413
    Zago AS, Kokubun E, Fenty-Stewart N, Park JY, Attipoe S, Hagberg J, Brown M (2010) Effect of physical activity and t-786C polymorphism in blood pressure and blood flow in the elderly. Arq Bras Cardiol 95(4):510–516
    Sandrim VC, Palei AC, Luizon MR, Izidoro-Toledo TC, Cavalli RC, Tanus-Santos JE (2010) eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J 10(1):40–45
    Erdos EG, Tan F, Skidgel RA (2010) Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55(2):214–220
    Mukae S, Aoki S, Itoh S, Iwata T, Ueda H, Katagiri T (2000) Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension 36(1):127–131
    Mukae S, Itoh S, Aoki S, Iwata T, Nishio K, Sato R, Katagiri T (2002) Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough. J Hum Hypertens 16(12):857–863
    Lee YJ, Tsai JC (2001) Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 50(11):1346–1350
    Woo SW, Bang S, Chung MW, Jin SK, Kim YS, Lee SH (2009) Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. J Clin Pharm Ther 34(5):561–567
    Grilo A, Saez-Rosas MP, Santos-Morano J, Sanchez E, Moreno-Rey C, Real LM, Ramirez-Lorca R, Saez ME (2011) Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough. Pharmacogenet Genomics 21(1):10–17
    Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H Jr, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 24(12):2393–2397
    Silva PS, Fontana V, Palei AC, Sertorio JT, Biagi C, Tanus-Santos JE (2011) Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. Eur J Clin Pharmacol 67(4):365–370
    Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12(3):177–182